Enantio- and Diastereoselective Total Synthesis of Belzutifan Enabled by Rh-Catalyzed Hydrogenation
- Org Lett. 2024 May 17;26(19):4059-4064. doi: 10.1021/acs.orglett.4c00982.
- 1. Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
- 2. Modeling and Informatics, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
- 3. Chemistry Service Unit, WuXi AppTec (Tianjin), Tianjin 300457, China.
Herein, we report a nine-step synthesis of belzutifan enabled by a novel Rh-catalyzed asymmetric hydrogenation to install the contiguous fluorinated stereocenters with high enantioselectivity. Moreover, the final ketone reduction in the synthesis proceeds with high diastereoselectivity, leading to the expedient assembly of the stereotriad. In contrast to the original 16-step synthesis, this route avoids a lengthy bromination-oxidation sequence and introduces the sulfone functionality via nucleophilic aromatic substitution, obviating the need for transition metal catalysis.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Biochemical Assay ReagentsResearch Areas: Others
-
Research Areas: Others